Flerie
Research Flerie (FLERIE) on Bullrun: market cap SEK 1.71B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFLERIE
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 1.71B
- Financial periodQ2 2026
- RevenueSEK 1.30M
- Net income-SEK 92.40M
- Free cash flow-SEK 9.10M
Valuation Snapshot
latest market cap is SEK 1.71B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -9.54 | SEK 540.20M | SEK 2.10M | SEK 3.38B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | SEK 1.71B | n/a | n/a | n/a |
About Flerie
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Flerie's market cap?
Flerie's market capitalization is SEK 1.71B.
What does Flerie do?
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.